Overview
Dirucotide is a potentially disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis, a chronic autoimmune disorder that primarily affects the joints. It inhibits the release of tumor necrosis factor (TNF), a pro-inflammatory agent which is believed to be one of the main drivers of the disease, and helps reduce joint inflammation, swelling and stiffness. Dirucotide is an effective treatment for rheumatoid arthritis, offering a practical alternative to more conventional non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. It is generally well-tolerated, with minimal side effects, and is often used in combination with other treatments to maximize its efficacy. Dirucotide has the potential to significantly improve the quality of life of those living with rheumatoid arthritis, offering a safe and effective treatment option.